New assay for the measurement of selenoprotein P as a sepsis biomarker from serum
New assay for the measurement of selenoprotein P as a sepsis biomarker from serum
复制标题
DOI:
10.1016/j.jtemb.2007.11.003
复制
发表时间:
2008-01-01
影响因子:
3.5
通讯作者:
Schomburg, Lutz
中科院分区:
文献类型:
--
作者:
Hollenbach, Birgit;Morgenthaler, Nils G.;Schomburg, Lutz
Selenium (Se) is incorporated into selenoproteins as the 21st proteinogenic amino acid selenocysteine. Serum Se concentrations decline during critical illness and are indicative of poor prognosis. Serum Se is mainly contained in the hepatically derived selenoprotein P (SePP) which controls the expression of antioxidative selenoproteins. Here, we describe the development of an immunoluminometric sandwich assay that uses two polyclonal sheep antihuman SePP antibodies. After assessing the stability of the analyte, we determined SePP concentrations in samples from healthy individuals and patients with sepsis. The analytical detection limit was 0.016 mg SePP/L serum. The assay was linear on dilution. SePP was stable in serum at room temperature for at least 24 h and resistant to six freeze-thaw cycles. Median SePP concentration in healthy individuals was 3.04mg SePP/L serum (25th-75th percentiles, 2.6-3.4mg/L) which corresponded to 98.4 mu g Se/L serum. The interlaboratory CV was 0.06 mg/L. There was no association with gender, but concentrations differed between young and older individuals. Median SePP concentrations were significantly (P